585 results on '"Hwang, Jin-Yong"'
Search Results
152. The Effect of Cilostazol on Arterial Stiffness in Patients Undergoing Percutaneous Coronary Intervention
153. THE PROGNOSTIC VALUE OF EXERCISE ECG TEST AND CARDIAC COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY FOR CARDIOVASCULAR EVENTS IN PATIENT PRESENTING WITH CHEST PAIN
154. PHARMACODYNAMIC EFFICACY OF PRASUGREL MAINTENANCE THERAPY AT IN-HOSPITAL AND ONE-MONTH TIME POINTS: COMPARISON BETWEEN ST-ELEVATION MYOCARDIAL INFARCTION AND NON-ST-ELEVATION ACUTE CORONARY SYNDROME
155. Paraparesis after Primary Percutaneous Coronary Intervention for ST-segment Elevation Myocardial Infarction: Combined Uncommon Complications of Acute Aortic Syndrome in a Patient
156. Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial.
157. Reliability and validity of the Korean version of the coronary revascularization outcome questionnaire.
158. ASSOCIATION BETWEEN BRACHIAL-ANKLE PULSE WAVE VELOCITY AND LONG-TERM OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION.
159. Abstract 11320: Long-Term Stent-Related and Patient-Related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents versus Zotarolimus-Eluting Resolute Stents in Real-World Practice: Three Year Results From the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries
160. Response to Letters Regarding Article, “Ischemic Postconditioning During Primary Percutaneous Coronary Intervention: The Effects of Postconditioning on Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction (POST) Randomized Trial”
161. TCTAP A-033 Reappraisal of Pharmacodynamic Effect of Adjunctive Cilostazol and High-dos Clopidogrel in East Asian ACS Patients
162. REAPPRAISAL OF PHARMACODYNAMIC EFFECT OF ADJUNCTIVE CILOSTAZOL AND HIGH-DOSE CLOPIDOGREL IN EAST ASIAN ACS PATIENTS
163. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity
164. Comparison of Computed Tomography Coronary Angiography and Exercise ECG Test for Diagnostic Accuracy in Real-World Practice
165. Pharmacodynamic Effects of Cilostazol Versus Clopidogrel in Stented Patients under Proton Pump Inhibitor Co-administration: The ACCEL-PARAZOL Study
166. A Case of Recurrent Spontaneous Hypoglycemia in a 73-year-old Woman with Congestive Heart Failure
167. Ischemic Postconditioning During Primary Percutaneous Coronary Intervention
168. Rehabilitation of Deteriorated Agricultural Waterways due to Polymer Cement Mortar
169. Remodeling of Deteriorated Irrigation Aqueducts Using Precast Polymer Concrete Flume
170. Risk Stratification Using Computed Tomography Coronary Angiography in Patients Undergoing Intermediate-Risk Noncardiac Surgery
171. A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients with Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study
172. Permanent Pacemaker Implantation in a Patient with MELAS Syndrome
173. TCT-735 Pharmacodynamic Effect of Adjunctive Cilostazol vs. High-dos Clopidogrel in Acute Coronary Syndrome Patients According to the CYP2C19 Genotype (ACCEL-GENOTYPE) study
174. TCT-734 Influence of Platelet Reactivity and Inflammation on Peri-procedural Myonecrosis in East Asian Patients Undergoing Elective Percutaneous Coronary Intervention
175. AS-302 Influence of Platelet Reactivity and Inflammation on Peri-procedural Myonecrosis in East Asian Patients Undergoing Elective Percutaneous Coronary Intervention
176. CILOSTAZOL PLUS STANDARD CLOPIDOGREL VERSUS DOUBLE-DOSE CLOPIDOGREL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS UNDERGOING PCI: PHARMACODYNAMIC EFFECT AND INFLUENCE OF GENETIC POLYMORPHISMS
177. PREOPERATIVE CARDIOVASCULAR RISK STRATIFICATION USING CARDIAC COMPUTED TOMOGRAPHY IN PATIENTS UNDERGOING INTERMEDIATE RISK NON-CARDIAC SURGERY
178. THE LOSS-OF-FUNCTION IMPACT OF CYP2C19*2 VS. *3 ALLELE IN PATIENTS UNDERGOING PCI TREATED WITH HIGH MAINTENANCE-DOSE CLOPIDOGREL OF 150 MG/DAY: THE RESULTS OF THE ACCEL-DOUBLE-2N3 STUDY
179. Permanent Pacemaker Implantation in a Patient with Cardiac Syncope Associated with Glossopharyngeal Neuralgia
180. Appropriateness of Adenosine Deaminase-Guided Management for Patients with Pericardial Effusion
181. Rupture and Spontaneous Sealing of a Coronary Aneurysm After Deployment of Drug-Eluting Stent
182. Stress-Induced Cardiomyopathy as a Complication of Permanent Pacemaker Implantation
183. Effect of CYP2C19*2 and *3 Loss-of-Function Alleles on Platelet Reactivity and Adverse Clinical Events in East Asian Acute Myocardial Infarction Survivors Treated With Clopidogrel and Aspirin
184. The concordance and correlation of measurements by multiple electrode and light transmittance aggregometries based on the pre-defined cutoffs of high and low on-treatment platelet reactivity
185. Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents
186. FIRST VALIDATION OF ADJUNCTIVE CILOSTAZOL LOADING EFFECT AND DOSAGE ON PLATELET INHIBITION: RESULTS OF THE ACCEL-LOADING STUDY
187. CONSENSUS DEFINITION-BASED CUTOFFS OF HIGH ON-TREATMENT PLATELET REACTIVITY: VALIDATION BETWEEN LIGHT TRANSMITTANCE AND MULTIPLE ELECTRODE AGGREGOMETRIES
188. Asymptomatic Left Ventricular Pseudoaneurysm Evaluated With Multimodality Cardiac Imaging
189. A Case of Spontaneous Coronary Artery Dissection Healed by Medical Treatment: Serial Findings of Coronary Angiography, Intravascular Ultrasound and Multi-Detector Computed Tomography
190. Isolated Left Main Coronary Artery Spasm Detected by Multidetector Computed Tomography
191. Delayed Ventricular Septal Rupture Following Blunt Chest Trauma
192. Cytochrome 2C19 Polymorphism and Response to Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention
193. AS-52: Cytochrome 2C19 Polymorphism and Response to Adjunctive Cilostazol versus High-Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: Results of the ACCEL-POLYMORPHISM Study
194. AS-249: A High-Maintenance-Dose Clopidogrel of 150-mg/day Cannot Overcome the Loss-of-Function Effect of the Cytochrome 2C19 Polymorphism
195. AS-251: The Cytochrome 2C19*2 and *3 Alleles Attenuate Response to Clopidogrel Similarly in East Asian Patients Undergoing Elective Percutaneous Coronary Intervention
196. AS-250: Impact of Genetic Polymorphisms on Response to Adjunctive Cilostazol to Dual Antiplatelet Therapy
197. AS-252: The Impact of Non-Cytochrome 3A4 Metabolized Statin in Patients with High Post-Clopidogrel Platelet Reactivity: The Results of the ACCEL-SWITCH Study
198. CYTOCHROME 2C19 POLYMORPHISM AND RESPONSE TO ADJUNCTIVE CILOSTAZOL VERSUS HIGH MAINTENANCE-DOSE CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
199. HIGH MAINTENANCE-DOSE OF CLOPIDOGREL (150 MG/D) CAN NOT OVERCOME THE LOSS-OF-FUNCTION EFFECT OF THE CYTOCHROME 2C19 POLYMORPHISM
200. THE IMPACT OF NON-CYTOCHROME 3A4 METABOLIZED STATIN IN PATIENTS WITH HIGH POST-CLOPIDOGREL PLATELET REACTIVITY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.